New warning OK'd for birth control patch

Jan 21, 2008

The U.S. Food and Drug Administration has approved a warning for the Ortho Evra Contraceptive Transdermal Patch label concerning the risk of blood clots.

The new label will include a warning that users of the birth control patch are at higher risk of pulmonary embolism from blood clots known as venous thromboembolism than women using birth control pills.

"For women that choose to use contraceptives, it is important that they thoroughly discuss with their health care providers the risks and benefits involved," said Dr. Janet Woodcock, the FDA's deputy commissioner for scientific and medical programs. "This is an example of FDA working in tandem with the drug manufacturer to keep the public informed of new safety data and epidemiological studies that may impact health decisions about the use of FDA approved products."

The FDA said it believes Ortho Evra is a safe and effective method of contraception when used according to the labeling, which recommends women with concerns or risk factors for serious blood clots talk with their healthcare provider about using Ortho Evra versus other contraceptive options.

The Ortho Evra Contraceptive Transdermal Patch is manufactured by Johnson and Johnson.

Copyright 2008 by United Press International

Explore further: Australia challenges 'misleading' Nurofen painkiller

add to favorites email to friend print save as pdf

Related Stories

Cebit 2015: DIY printing custom touch-sensitive displays

21 minutes ago

Computer scientists from Saarbrücken have developed a technique that could enable virtually anyone to print out customized displays of their own in future—in all shapes and sizes and onto various materials. ...

Buckybomb shows potential power of nanoscale explosives

21 minutes ago

(Phys.org)—Scientists have simulated the explosion of a modified buckminsterfullerene molecule (C60), better known as a buckyball, and shown that the reaction produces a tremendous increase in temperatur ...

Recommended for you

Breakthrough to take the pain out of catheters

15 hours ago

A new pharmaceutical product that could significantly improve quality of life for catheter users all over the world is to be developed by Queen's University Belfast after it won a national award.

FDA warning: men's testosterone drugs overused (Update)

Mar 03, 2015

The Food and Drug Administration is warning doctors against over-prescribing testosterone-boosting drugs for men, saying the popular treatments have not been established as safe or effective for common age-related ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.